Trial
NCT03908333
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
Cancer Research UK; Stand Up To Cancer; Lustgarten Foundation; Destroy Pancreatic Cancer; Translational Genomics Research Institute; HonorHealth Research Institute
Condition
Metastatic Pancreatic Cancer
Intervention
Ascorbic Acid
Why stopped
Request to close per funding sponsor. Site not moving forward with trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-30